Numinus Wellness ( (TSE:NUMI) ) just unveiled an announcement.
Numinus Wellness Inc. has received state certification in Colorado for its Psychedelic-Assisted Therapy Training Program, a significant milestone under the Natural Medicine Health Act. This approval allows Numinus to offer a comprehensive training pathway for healthcare practitioners, ensuring they are equipped to provide safe and ethical psilocybin-assisted therapy, thus enhancing the company’s position in the expanding field of psychedelic-assisted treatments.
More about Numinus Wellness
Numinus Wellness Inc. is a mental healthcare company that focuses on advancing traditional and innovative behavioral health treatments, including safe, evidence-based psychedelic-assisted therapies. The company is at the forefront of integrating these therapies into mainstream clinical practice, aiming to heal rather than just manage symptoms of depression, anxiety, trauma, pain, and substance use.
YTD Price Performance: 7.50%
Average Trading Volume: 291,450
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: C$13.86M
For detailed information about NUMI stock, go to TipRanks’ Stock Analysis page.